Oxygen Delivery Index™

represents a function assessment of the microcirculatory system to assess circulatory failure on an individual patient basis


enables capturing of microvascular data bedside using optical instruments for further assessment of microcirculatory function


enables advanced analysis of microvascular hemodynamics and oxygen delivery
for assessment of microcirculatory function

About us

ODI Medical is developing technology for bedside for evaluation of the circulatory failure based on the assessment of the microcirculation. Our concept, the Oxygen Delivery Index™, may be used for a wide range of clinical applications such as assessing patients on mechanical heart and lung machines, evaluation of toxicity of chemotherapy, early detection of evolving sepsis, and mass screening of conditions such as Ebola, bird flu or endemic meningitis. ODI Medical is commercializing its technology and concepts on the foundation of 30 years research from its founder, Professor Knut Kvernebo, from The Oslo University Hospital (OUS), Oslo, Norway.   

Latest News

Oslo 2016-10-15 From today ODI Medical has office space in The Medical Growth House located at...
Oslo 2016-01-01 ODI Medical has been granted 7.4 mill NOK over 2 years from The Research Council...
Oslo 2015-06-01 ODI Medical Founder Professor Knut Kvernebo at Oslo University Hospital has...

Management Team

Knut Kvernebo, Founder and CMO

Alison Sundset, CEO

Svein-Erik Måsøy, CIO

Ute Wiesemann, Q&R Director

Kjeld Rimberg, Chairperson